Endorsers of the ICBCC Patient Impact Statement

Last Thursday 24 February the ICBCC Policy Strategy Working Group met to discuss on the Policy Strategy to address the specific impact of the pandemic on immunocompromised blood cancer patients (both acute and chronic) in a workshop-style setting. The meeting was facilitated by our partner Patvocates.

During the 2 hour workshop the group managed to define the actionable objectives from the impact statement and define the primary stakeholders and the level of lobbying needed (international/country level) for each of the objectives. In order to finalise the policy strategy and prioritise the creation of the tools and with the aim of eliciting a broad representative sample, we want to ask all statement endorsers to please vote their top 5 priorities when it comes to objectives. You can do this by adding votes in the Online Tool Groupmap which you can access via the following link: https://join.groupmap.com/413-EC5-D36Please submit your votes by end of business Thursday 3rd of March.

As final step, we ask you as well to add suggestions on which tools you would consider most useful for you for each of the actions (template letters, social media images, flyers, etc.). To do so, you can add comments in each of the boxes.

Your input will help us provide tools that really suit your needs.

We thank you in advance for your speedy response to the above request!

On behalf of the CLLAN Steering Committee and the International COVID-19 Blood Cancer Coalition” (ICBCC)